Search results
People also ask
Who is Clerkenwell health?
Who are Clerkenwell health & Psyence group?
Why did Clerkenwell health start in London?
What services does Clerkenwell Medical Practice offer?
Europe's pioneering hub for mental health research—where innovation meets care. Our purpose-built clinic is Europe’s first commercial research site specialising in psychedelics and advanced technologies. Now accepting patients to shape the future of mental healthcare.
- We support
Receive high quality care. Clinical trials are free to...
- About Us
2021 was momentous for Clerkenwell Health, and laid strong...
- Blog
Clerkenwell Health Taps Top Academics and Expands...
- Investors
Clerkenwell Health is a fast-growing clinical research...
- Contact
There are two ways you can get involved in our trials as a...
- Team
Our rare expertise in mental health and psychedelic-assisted...
- Press
Launched early last year, Clerkenwell Health still has a...
- UK Set to Become Hub of Psychedelic Research
About Clerkenwell Health. Clerkenwell Health is an...
- We support
Receive high quality care. Clinical trials are free to participate and cover all your expenses while providing you with high-quality care. Our clinical team are subject experts with a specialism in psychedelics and always prioritise your wellbeing.
Jul 7, 2021 · Clerkenwell Health have signed their first multi-million pound contract to design and run multi-phase trials with Psyence Group. Psyence Group is a Canadian-listed life science biotechnology company pioneering the use of natural psilocybin to heal psychological trauma and its mental health consequences in the context of palliative care.
Clerkenwell Health is building the clinical research expertise and care delivery platform to advance the next wave of mental health and neurological treatments and help patients access them.
The company's healthcare clinic's therapy provides preparation, treatment sessions, and subsequent follow-up by experienced psychotherapists, helping healthcare with robust and clinically validated data sets to prove the efficacy of psilocybin-assisted therapy versus existing standards of care.
- 42
Oct 10, 2022 · Clerkenwell Health, a psychedelic-specialist clinical research organisation, has raised £2.1 million in seed funding, bringing the total to date up to £2.5 million, which will be used to get...
Europe’s first organisation dedicated to running clinical trials for psychedelic-assisted therapies.